Physician profile
Mini Gupta
NPI 1528117389
$4,162.90
in general payments reported to CMS, 2019-2025
37 companies · $1,595 in 2025
The $1,595 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,107 · 2020: $676 · 2022: $30.34 · 2023: $200 · 2024: $555 · 2025: $1,595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,350.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $596.62 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $464.60 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Astellas Pharma US INC | $385.55 | 2019-2025 | Veozah |
| Kowa Pharmaceuticals America, INC. | $368.60 | 2019-2025 | Zoryve, Livalo, Seglentis |
| Pfizer INC. | $315.96 | 2019-2025 | |
| Lilly USA, LLC | $229.28 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Merck Sharp & Dohme LLC | $189.42 | 2019-2020 | |
| Abbvie INC. | $180.64 | 2022-2025 | |
| Daiichi Sankyo INC. | $167.23 | 2019-2020 | |
| Glaxosmithkline, LLC. | $145.81 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Exact Sciences Corporation | $129.96 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.85 | 2019-2025 | Xifaxan |
| Sanofi Pasteur INC. | $84.18 | 2019-2024 | |
| Amgen INC. | $79.43 | 2019-2020 | |
| Bausch Health US, LLC | $77.59 | 2019-2024 | Wellbutrin, Aplenzin |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mini Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.